Trial of Spiritual Care Interventions for Patients With Cancer
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT07408310
- Status
- Recruiting
Conditions
- Advanced Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spiritual Care Intervention #1 — BEHAVIORALExperimental
- Spiritual Care Intervention #2 — BEHAVIORALExperimental
- Spiritual Care Intervention #3 — BEHAVIORALActive Comparator
Study Details
This study aims to determine the effects of 2 spiritual care interventions. Spiritual wellness and healthcare service utilization will be measured from a sample of advanced cancer patients recruited from outpatient settings.
Key Dates
- Start date
- Mar 24, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2029
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 288 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Spiritual Care Intervention #1This is an experimental condition arm. Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
- Experimental: Spiritual Care Intervention #2This is also an experimental condition arm. Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
- Active Comparator: Spiritual Care Intervention #3This is the active comparator condition arm. Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
Primary Outcome Measure
Patients' spiritual wellness as assessed by measures of spiritual well-being [ Time Frame: 2 months ]
Central Contacts
- Madison K Pavao, B.S.(646)962-5650
- Paul K Maciejewski, Ph.D.646-962-7169
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York Presbyterian Brooklyn Methodist Hospital | New York | New York | 11215 | Alan B Astrow, M.D. (PRINCIPAL_INVESTIGATOR) |
| The University of Texas Medical Branch, Galveston | Galveston | Texas | 77555 | Mukaila Raji, M.D. (PRINCIPAL_INVESTIGATOR) |
| M.D. Anderson Cancer Center | Houston | Texas | 77030 | David Hui, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Psychophysical Studies of Cancer Therapy PainRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · I-Mab Biopharma US Limited · Orange, California
- A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerPHASE1/PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · New York, New York